Jennifer Havens is a Psychiatry physician. OpenAlex indexes 182 publications with 6,096 citations (h-index 39); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
115 Central Park W Ofc 5
New York, NY 100234198
Telephone
212-579-9209Registry record last updated 8 Jul 2007.
Clinical trials
- The Kentucky Viral Hepatitis Treatment Study
Sponsor: Jennifer Havens
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 1994–1995 per NIH RePORTER. The latest:
- MENTAL HEALTH SERVICES FOR FAMILIES AFFECTED BY HIV
Columbia Presbyterian Medical Center
FY1995UD5SM051688 - MENTAL HEALTH SERVICES FOR FAMILIES AFFECTED BY HIV
Columbia Presbyterian Medical Center
FY1994UD5SM051688
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The continued rise of methamphetamine use among people who use heroin in the United States
Drug and Alcohol Dependence
2021 - A nationally representative analysis of “twin epidemics”: Rising rates of methamphetamine use among persons who use opioids
Drug and Alcohol Dependence
2019 - Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting system
Drug and Alcohol Dependence
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Scheltens
Inserm
Rafael Tabarés‐Seisdedos
Universitat de València
Nick C. Fox
UK Dementia Research Institute
Perminder S. Sachdev
Department of Health and Aged Care
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”